This inventor holds 4 USPTO granted patents and 3 published patent applications. Top assignees: Auris Medical Ag, National Institute of Health and Medical Research. Active years: 2013-2021.
Company Filing History:
4 out of 5 
3 out of 1,853 
Years Active: 2013-2021
Title: Jerome Ruel: Innovator in Tinnitus Treatment
Introduction
Jerome Ruel is a notable inventor based in Montpellier, France. He has made significant contributions to the field of audiology, particularly in the treatment of tinnitus. With a total of 4 patents to his name, Ruel's work focuses on innovative methods to address cochlear excitotoxicity.
Latest Patents
Ruel's latest patents include groundbreaking methods for the treatment of tinnitus induced by cochlear excitotoxicity. These inventions involve the administration of a pharmaceutical composition containing an NMDA receptor antagonist. This treatment is designed for individuals suffering from tinnitus caused by various factors such as acoustic trauma, presbycusis, ischemia, anoxia, and the use of ototoxic medications. Additionally, Ruel's patents encompass a novel screening method for identifying compounds effective in treating and preventing tinnitus through an electrophysiological test method.
Career Highlights
Throughout his career, Jerome Ruel has worked with prominent organizations, including Auris Medical AG and the Institut National de la Santé et de la Recherche Médicale. His experience in these institutions has allowed him to advance his research and develop effective treatment methods for tinnitus.
Collaborations
Ruel has collaborated with esteemed colleagues in his field, including Matthieu Guitton and Jean-Luc Puel. These partnerships have contributed to the depth and impact of his research.
Conclusion
Jerome Ruel's innovative work in the treatment of tinnitus showcases his dedication to improving the lives of those affected by this condition. His patents and collaborations reflect a commitment to advancing medical science and providing effective solutions for auditory health.